February 11, 2009 2:06 PM
- Text
Doctors, Insurance Firms Duel On Generics
Emmett Curran poses with his prescription medication at his apartment, in Lynn, Mass., on Oct. 29, 2008. After 10 years of taking the cholesterol medicine Lipitor, which has no low-cost generic equivalent, Curran's new insurer under Medicare refused to co (AP PHOTO)
(AP)
All the doctors had to do was show up, enjoy a free dinner at an elegant Rochester, N.Y., area restaurant specializing in steaks, chops and top-shelf wines, and pocket $100 on the way out the door.
Health insurance companies had invited the physicians to hear a pitch about the benefits of prescribing generic drugs instead of their pricier, name-brand competitors.
Meet the flip side of a concern about corporate influence in the doctor's office that's been criticized - often stridently - when the pharmaceutical industry entices doctors to prescribe brand-name drugs. Under pressure, that industry has since reined in its promotional efforts.
But insurance companies are allowed to push doctors toward cheaper prescriptions, frequently by offering the physician a form of bonus, a cut from the savings that insurance companies get when doctors prescribe generic drugs.
For example, Independent Health, a Buffalo, N.Y.-based insurer, offered doctors who prescribe 70 percent or more generic prescriptions in a month a bonus of 50 cents per patient per month. A doctor seeing 500 patients per month who meets the 70 percent minimum can collect $3,000 a year.
"On either side you've got corporate bottom-line interests putting pressure on physicians who should be putting patients first," said Dr. Jean Silver-Isenstadt, executive director of the National Physicians Alliance, an industry organization that prioritizes patient interests.
John Rodgers, executive vice president and chief marketing officer for Independent Health, said the incentive program rewards doctors for prescribing generics when possible - but it doesn't punish them if they don't.
"Our plan doesn't agree to force people off of a drug if a person makes a personal choice they can continue that drug with a higher copay," he said.
In New York, state Sen. Jeffrey Klein introduced legislation that would prevent insurance companies from offering physicians incentives. A grandfather clause would require HMOs to continue providing brand-name drugs to patients already benefiting from it. But none of these bills have gotten serious traction in state legislatures.
Last year, the American Medical Association warned that it considered the bonuses kickbacks and said doctors who accept payment from an insurer for switching a patient from a brand name to a generic drug could potentially face criminal and civil liability under federal statutes.
And caught in the middle, physicians warn that when a medical decision is taken out of a doctor's hands, it can hurt patients, such as 77-year-old Emmett Curran of Lynn, Mass.
Health insurance companies had invited the physicians to hear a pitch about the benefits of prescribing generic drugs instead of their pricier, name-brand competitors.
Meet the flip side of a concern about corporate influence in the doctor's office that's been criticized - often stridently - when the pharmaceutical industry entices doctors to prescribe brand-name drugs. Under pressure, that industry has since reined in its promotional efforts.
But insurance companies are allowed to push doctors toward cheaper prescriptions, frequently by offering the physician a form of bonus, a cut from the savings that insurance companies get when doctors prescribe generic drugs.
For example, Independent Health, a Buffalo, N.Y.-based insurer, offered doctors who prescribe 70 percent or more generic prescriptions in a month a bonus of 50 cents per patient per month. A doctor seeing 500 patients per month who meets the 70 percent minimum can collect $3,000 a year.
"On either side you've got corporate bottom-line interests putting pressure on physicians who should be putting patients first," said Dr. Jean Silver-Isenstadt, executive director of the National Physicians Alliance, an industry organization that prioritizes patient interests.
John Rodgers, executive vice president and chief marketing officer for Independent Health, said the incentive program rewards doctors for prescribing generics when possible - but it doesn't punish them if they don't.
"Our plan doesn't agree to force people off of a drug if a person makes a personal choice they can continue that drug with a higher copay," he said.
Some states want to more closely monitor the relationship between insurance industry representatives and doctors. In Massachusetts, a pending bill would regulate incentive plans between insurance carriers and providers. A Michigan proposal would ban financial incentives in exchange for prescribing a generic medication. That measure would allow insurance companies to compensate doctors for the time it took to evaluate whether a switch was best for the patient.
In New York, state Sen. Jeffrey Klein introduced legislation that would prevent insurance companies from offering physicians incentives. A grandfather clause would require HMOs to continue providing brand-name drugs to patients already benefiting from it. But none of these bills have gotten serious traction in state legislatures.
Last year, the American Medical Association warned that it considered the bonuses kickbacks and said doctors who accept payment from an insurer for switching a patient from a brand name to a generic drug could potentially face criminal and civil liability under federal statutes.
And caught in the middle, physicians warn that when a medical decision is taken out of a doctor's hands, it can hurt patients, such as 77-year-old Emmett Curran of Lynn, Mass.
- 1
- 2
- Next Page »
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- 4.5 million Americans over 50 have artificial knees
- Marijuana-smoking motorists twice as likely to crash
- Skin cancer self-exam: What to look for (PHOTOS)
- Things You Didn't Know About Your Penis
- HealthPop: Online dating and jaw engraving
- PICTURES: 15 Shocking Sexual Fetishes
- Christina Hendricks: Too Big for Hollywood?
- John Dye Dies: What Killed "Angel" Star?
- Whitney Houston back in rehab: Why?
- Online dating downsides, romantic tattoo gone wrong: HealthPop Valentine's Day video
- Woman spotlights uterus didelphys on talk show
- 8 Tips For Losing Weight After Pregnancy
- Caffeine inhalers - the next club drug?
- Demi Moore's hospitalization spotlights whippets
- Norovirus outbreak hits Rider University in N.J
- Anti-Rape Condoms Fight World Cup Sex Assault
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Airbus CEO warns of trade conflict over carbon tax
- Big fight looms over Obama's budget proposal
- Gay marriage bills proposed in Aussie Parliament
- Teenage Tibetan nun sets herself on fire in China
on Facebook Most Discussed Stories
on CBS News






